Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Datadog Inc (DDOG) vs Nuwellis Inc (NUWE) Price & Performance

Datadog IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Datadog Inc vs Nuwellis Inc — how do they compare? Datadog Inc trades at $272.51 (market cap $97.43B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Datadog Inc is far larger — about 44286.4× Nuwellis Inc's market cap, and Datadog Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Datadog Inc for 76 Days and Nuwellis Inc for 26 Days on average.

DDOGNUWE
Market Cap
$97.43B$2.20M
Volume
1,586,926121,544
Sector
TechnologyHealth
52-Week High
$288.15$146.65
52-Week Low
$102.62$0.68
Typical Hold Time
76 Days26 Days
Enterprise Value
$93.72B-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Datadog Inc

Datadog (DDOG) trades at $271.34, down 2.48% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while oscillators are neutral. Fundamentally, revenue growth is robust, rising from $1.7B in 2022 to $3.43B in 2025, though net income margins are volatile. Recent earnings beats and accelerating enterprise customer adoption, particularly in AI and cloud observability, support positive sentiment.

The outlook is favorable given analyst consensus and AI-driven demand, but high valuation multiples (P/E 542.68) and negative net cash flow pose risks. Upside potential exists if the company sustains earnings momentum and expands profitability. Key risks include competitive pressures and execution challenges in a high-growth environment.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DDOG
47% Buy53% Sell
Avg holding period · 76 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Datadog Inc

Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.

Read more on DDOG →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →